Location: United States, California, San Luis Obispo
Total raised: $1.55M
Investors 1
| Date | Name | Website |
| 12.11.2023 | Streamline... | streamline... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.06.2023 | Seed | $1.55M | - |
Mentions in press and media 11
| Date | Title | Description |
| 27.08.2025 | Former FDA Chief Counsel Joins Plan A™ to Launch Male Birth Control | Share Share Share Share Email Peter Barton Hutt, former Chief Counsel at the FDA and pioneer of medical device regulatory policy, joins as Plan A™ concludes successful U.S. clinical trials. Los Angeles, CA – August 27, 2025 – NEXT Life Scie... |
| 03.04.2025 | NEXT Life Sciences Announces Successful Plan A™ Delivery Device Clinical Trial in Australia | Australian Clinical Results Demonstrate 100% Success Rate for New Delivery Method Results Demonstrate the Effectiveness of a Revolutionary Male Contraceptive Delivery System Contraception has been lacking innovation for decades; we at NEXT ... |
| 24.10.2024 | NEXT Life Sciences Appoints Dr. Darlene Walley as CEO of Plan A™ | Announcing Dr. Darlene Walley as CEO of Plan A™ and Peter Barton Hutt joining the NEXT Advisory Board. Peter Barton Hutt: Former FDA Chief Counsel joins the Advisory Board of NEXT Life Sciences We are thrilled to bring Dr. Darlene Walley on... |
| 28.02.2024 | Male Contraceptive Initiative Supports the Launch of Plan A™ Male Birth Control | NEXT Life Sciences, Inc. (NEXT) is announcing its partnership with Male Contraceptive Initiative (MCI), the largest 501(c)(3) non-profit in the world dedicated to advancing male contraception. MCI grants $400K to support NEXT’s clinical tri... |
| 12.02.2024 | NEXT Life Sciences Announces Successful Clinical Evaluation of the Delivery Method for Plan A™ Contraception for Men | Novel method represents an evolution for male contraceptive research. LOS ANGELES, CALIFORNIA, UNITED STATES, February 12, 2024 /EINPresswire.com/ -- NEXT Life Sciences, the company designing a non-hormonal, long-lasting, and reversible mal... |
| 04.08.2023 | World’s Leading Vasectomists and Male Contraceptive Experts Join in Support of Plan A: Male Birth Control | NEXT Life Sciences, the team developing Plan A™, the long-lasting, reversible contraceptive for men, announced new appointments to its Medical Advisory Board. LOS ANGELES, CALIFORNIA, UNITED STATES, August 4, 2023/EINPresswire.com/ -- NEXT ... |
| 18.07.2023 | NEXT Life Sciences Announces Dr. Charles Carignan as Chief Medical Officer and Cindy Domecus as Chief Regulatory Advisor | LOS ANGELES, CALIFORNIA, UNITED STATES, July 18, 2023/EINPresswire.com/ -- NEXT Life Sciences, the team developing Plan A™, a long-lasting, reversible contraceptive for men, announced today its appointment of Dr. Charles Carignan as its Chi... |
| 12.07.2023 | Bipartisan Congressional Briefing: Insights and Opportunities to Improve Family Planning Options for Maternal Wellbeing | Congressional Briefing on Maternal Mental Health, July 12, 2023 Policy Center for Maternal Mental Health & NEXT Life Sciences host a Congressional briefing on developments in family planning, including male contraception WASHINGTON, DC,... |
| 05.06.2023 | NEXT Life Sciences Raises $1.55M in Seed Funding | NEXT Life Sciences, a Los Angeles, CA-based medical device company raised $1.55M in Seed funding. Backers were not disclosed. The company intends to use the funds to support the development and commercialization of Plan A. Led by L.R. Fox, ... |
| - | NEXT Life Sciences | “Home | NEXT Life Sciences” |
Show more